Neoadjuvant Gemcitabine Plus Cisplatin With or Without Durvalumab in Resectable Biliary Tract Cancer

Name: Neoadjuvant Gemcitabine Plus Cisplatin With or Without Durvalumab in Resectable Biliary Tract Cancer
License: Public Domain

Asan Medical Center

ClinicalTrials.gov · Datasets · License: Public Domain

biliary tract neoplasms, gallbladder cancer, cholangiocarcinoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 143552
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.